TY  - JOUR

T1  - Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)

JO  - Circulation

UR  - https://doi.org/10.1161/circulationaha.120.052186

PY  - 2020/11/13

AU  - Lee MMY

AU  - Brooksbank KJM

AU  - Wetherall K

AU  - Mangion K

AU  - Roditi G

AU  - Campbell RT

AU  - Berry C

AU  - Chong V

AU  - Coyle L

AU  - Docherty KF

AU  - Dreisbach JG et al

ED  - 

DO  - DOI: 10.1161/circulationaha.120.052186

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 143

IS  - 6

SP  - 516

EP  - 525

Y2  - 2025/12/05

ER  -